P1.13-33 Ex Vivo 2*2*2 Tumor Tissue Explant Culture for Precision Medicine in Immunotherapy and TKI Progressors in Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.890
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Radiomics in Precision Medicine for Lung Cancer

Translational Lung Cancer Research
Oncology
2017English

Up-Regulation of ALG-2 in Hepatomas and Lung Cancer Tissue

American Journal of Pathology
Forensic MedicinePathology
2003English

Prospects of IL-2 in Cancer Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Pharmacogenetics in Type 2 Diabetes: Precision Medicine or Discovery Tool?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Blood-Based Biomarkers for Precision Medicine in Lung Cancer: Precision Radiation Therapy

Translational Lung Cancer Research
Oncology
2017English

Caspase-2 Impacts Lung Tumorigenesis and Chemotherapy Response in Vivo

Cell Death and Differentiation
Cell BiologyMolecular Biology
2014English

New Advances in the Precision Medicine of Lung Cancer

Current Pathobiology Reports
Forensic MedicineCancer ResearchPathologyCell BiologyMolecular Biology
2012English

BAI1‑associated Protein 2‑like 2 Is a Potential Biomarker in Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Immunotherapy in Glioblastoma: Emerging Options in Precision Medicine

CNS oncology
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy